Stockreport

Oddity Tech: No Fundamental Weakness Seen; I Reiterate Buy [Seeking Alpha]

ODDITY Tech Ltd. - Class A Ordinary Shares  (ODD) 
PDF MethodIQ and ODDITY Labs transform ODD into a defensible technology platform, offering proprietary molecules and higher efficacy in the $27B acne and dermatology market [Read more]